4.2 Review

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

Journal

CURRENT RHEUMATOLOGY REPORTS
Volume 17, Issue 10, Pages -

Publisher

SPRINGER
DOI: 10.1007/s11926-015-0540-1

Keywords

Psoriasis; Psoriatic arthritis; Risk factors; Epidemiology

Categories

Funding

  1. Abbvie
  2. Novartis
  3. Pfizer
  4. Janssen
  5. Amgen
  6. Merck
  7. Coherus

Ask authors/readers for more resources

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10 % of patients with psoriasis with higher prevalence seen in patients with more extensive skin disease. Early identification of PsA may result in improved outcomes. While it remains unclear which patients with psoriasis will develop PsA, several studies have identified potential risk factors for PsA among patients with psoriasis. This review examines the basic epidemiologic principles of identifying risk factors and reviews the evidence to date about risk factors for PsA among patients with psoriasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available